Comments
Commented by Armin Schulz on July 14th, 2021 | 10:54 CEST
Cardiol Therapeutics, CureVac, Bayer - Where is the journey heading?
One might think that the pharmaceutical industry is the big winner of the Corona Crisis. However, according to a study by EY, this is not the case. Sales did increase by an average of 4.4% at the largest pharma companies, a much better result than in many other industries, but compared to 2019, growth actually fell by 8.4%. That is due to the postponement of medical treatments due to the Corona Crisis. The industry benefits from the ever-increasing number of elderly people worldwide and, at the same time, the development of new drugs. As a result, sales and profits have increased even during the crisis. We, therefore, highlight three companies from the pharma sector.
Read
Commented by Nico Popp on July 14th, 2021 | 09:03 CEST
Standard Lithium, Blackrock Silver, NIU: Investing below the radar
Electric cars, wind turbines and solar cells: They all cannot do without critical raw materials. While lithium is closely associated with the boom in consumer electronics and electromobility, silver is familiar as an industrial metal at a second glance. Gold's little brother is still running in step with the best-known of all precious metals. However, analysts, such as those from Commerzbank, emphasize the growing importance of silver as an industrial metal and expect industrial demand for silver to reach record levels. We present three values around new technology and raw materials.
Read
Commented by André Will-Laudien on July 13th, 2021 | 11:21 CEST
TeamViewer, wallstreet:online, Deutsche Post - The digital winners list!
When the dot-com boom took off at the turn of the millennium, many immature and unpromising business models came onto the market. Every idea needed a stock market listing - then the techno-crash followed and many of the companies had already disappeared again. The Covid pandemic triggered a surge in digitization - some new achievements now determine the working world of every individual and change society as a whole. The successful business models show their strengths primarily in the areas of life that are now in the foreground: Distant Working, Fintech and Delivery Systems. We take a look at the cards of three protagonists.
Read
Commented by Nico Popp on July 13th, 2021 | 10:42 CEST
JinkoSolar, Barsele Minerals, Newmont: The takeover merry-go-round is spinning
Raw materials are the key to new technology. Whether silver, copper or other metals - many technologies, such as electric cars and solar panels, drive demand for metals. As these technologies triumph, so does the demand for raw materials. Using three stocks as examples, we explain how investors can profit.
Read
Commented by Stefan Feulner on July 13th, 2021 | 10:05 CEST
Bayer, Almonty Industries, Daimler - Shortages without end
The shortage of semiconductors weighs heavily on the auto industry. According to a study by the Duisburg-based Center for Automotive Research, it will be responsible for the loss of production of around five million vehicles this year alone. An end to the chip shortage is not yet in sight. Meanwhile, the next crisis due to the lack of raw materials is already just around the corner. Due to the rapid growth in electromobility, the high demand for lithium-ion batteries means that the next failures are pre-programmed.
Read
Commented by Carsten Mainitz on July 13th, 2021 | 07:55 CEST
BioNTech, Defence Therapeutics, Formycon - Which biotech stock suits which investor?
Corona is and remains the threat of the hour. In this respect, it is not surprising that the papers of the German vaccine pioneer BioNTech have gone on a fabulous journey. Other companies are still trying to jump on this bandwagon, too. For example, both Canada's Defence Therapeutics and Munich-based Formycon AG are researching a Covid-19 vaccine. However, these developments are at very different stages. In addition, the further product spectrum differs significantly in some cases. But which share is the right one for the portfolio? We took a closer look at the three dissimilar siblings.
Read
Commented by Stefan Feulner on July 12th, 2021 | 13:36 CEST
NIO, Kainantu Resources, BASF - Bright prospects
The first half of the 2021 stock market year is over, and the stock market indices continue to march from high to high. While some market participants were hoping for a stronger correction after the Corona rally, they have been disappointed so far. The FED has now laid the foundation for further rising prices. It sees the rising inflation, which is currently at 5% in the USA, as temporary. In favor of growth, interest rates will remain at historic lows for the time being. In addition, the bond-buying program of the monetary guardians continues unabated - a feast for the stock markets.
Read
Commented by Nico Popp on July 12th, 2021 | 12:22 CEST
Barrick Gold, Carnavale Resources, Yamana Gold: Where gold still shines
Public debt in Germany has exceeded the EUR 2.2 trillion mark for the first time, the Federal Statistical Office announced a few weeks ago. Per capita, the debt thus stands at EUR 26,532. Of course, such figures also unsettle investors. If the public sector is so indebted, this could also impact future monetary policy - after all, rising interest rates would significantly increase the cost of refinancing. That is an argument for the ultra-loose monetary policy to continue. That includes all the negative consequences, such as rising prices for tangible assets and products for daily use.
Read
Commented by Armin Schulz on July 12th, 2021 | 11:32 CEST
Aspermont, ProSiebenSat.1 Media, CLIQ Digital - profit from digitalization of media companies
In Germany, according to a McKinsey study, just 10% of digital potential is being exploited. Anyone who thinks that it is developing sluggishly in Germany is wrong. According to the study, even if the US leads the way with big tech companies at 18%, the potential is far from being exhausted. Digitization has become enormously important for media companies, particularly as the young generation consumes up to 90% of its content via smartphones. 90% of this content comes from social media. As a traditional media company with print or TV content, it is increasingly difficult to reach the coveted target group. The only way is to dovetail traditional content with digital media. Today we focus on three media companies and how they are dealing with this challenge.
Read
Commented by Carsten Mainitz on July 12th, 2021 | 10:07 CEST
CureVac, XPhyto Therapeutics, Paion - Where are the turning points?
"Opportunity and risk are two sides of the same coin", that is to say, with great potential returns, there is also the risk of incurring significant price losses. The biotechnology sector, in particular, offers investors a broad universe in which to find lucrative investments. We present three exciting ideas below. Who is winning the race?
Read